Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Research in context

Summary: Background: Erdheim-Chester disease (ECD) is a rare histiocytosis that may overlap with Langerhans Cell Histiocytosis (LCH). This “mixed” entity is poorly characterized. We here investigated the clinical phenotype, outcome, and prognostic factors of a large cohort of patients with mixed EC...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, Francesco Peyronel, Gianmarco Lugli, Irene Trambusti, Gildas Baulier, Mathilde de Menthon, Tanguy Le Scornet, Eric Oziol, Nicole Ferreira-Maldent, Olivier Hermine, Benoit Faucher, Dirk Koschel, Nicole Straetmans, Noémie Abisror, Benjamin Terrier, François Lifermann, Jerome Razanamahery, Yves Allenbach, Jeremy Keraen, Sophie Bulifon, Baptiste Hervier, Annamaria Buccoliero, Frederic Charlotte, Quentin Monzani, Samia Boussouar, Natalia Shor, Annalisa Tondo, Stephane Barete, Ahmed Idbaih, Abdellatif Tazi, Elena Sieni, Zahir Amoura, Jean-François Emile, Augusto Vaglio, Julien Haroche
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-07-01
Serija:	EClinicalMedicine
Teme:	Erdheim-Chester disease Langerhans BRAF Histiocytosis Mixed histiocytosis Pediatric histiocytosis
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2589537024002372
Oznake:	Označite Brez oznak, prvi označite!